EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting KPC-Producing Klebsiella pneumoniae Biofilms: Genomic Profiles, Clinical Outcomes and Novel Combinations

Chiara Papalini, Giulia Bicchieraro, Luigi Tordelli Ruda iD, Alicia Yoke Wei Wong iD, Claudia Battistelli, Giovanni Genga, Andrea Tommasi iD, Anna Gidari, Daniela Francisci, Giuseppe Vittorio De Socio iD, Roberta Spaccapelo iD, Donatella Pietrella iD und 3 weitere

Microorganisms · 14.08.2026 · 14 (8) · 1790

DOI: 10.3390/microorganisms14081790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 14.08.2026. Verfasst von Chiara Papalini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, Section of Infectious Diseases, University of Perugia, 06129 Perugia, Italy. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New beta-lactam/beta-lactamase inhibitor combinations (BL/BLICs) are licensed for Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) infections. However, data regarding their efficacy against bacterial biofilms and the potential of synergistic combinations remain limited. This study evaluated their efficacy on planktonic and biofilm forms of KPC-Kp isolated from catheter-related bloodstream infections (CRBSIs), correlating findings with genomic and clinical data. Twelve KPC-3-harboring isolates (ST512, n = 7; ST307, n = 3; ST101, n = 2) were characterized via whole-genome sequencing. Ceftazidime/avibactam (CAZ/AVI), meropenem/vaborbactam (MEM/VAB), and imipenem/relebactam (IMI/REL) were tested alone or combined with fosfomycin (FOS), cefepime (FEP), meropenem (MEM), or imipenem (IMI) using checkerboard assays. All BL/BLICs alone showed significant, comparable efficacy against biofilm-producing strains. However, combination testing revealed heterogeneous synergistic profiles. CAZ/AVI combined with MEM, IMI, or FEP achieved 100% synergy in both planktonic and biofilm states. MEM/VAB-based combinations demonstrated consistent synergy (50–100%), whereas IMI/REL showed higher synergistic rates in biofilm than in planktonic forms. Conversely, FOS-based regimens were significantly less effective against biofilms. These findings provide a clinical rationale for selecting optimized dual regimens to eradicate biofilms, offering a critical therapeutic strategy to preserve vascular devices when catheter removal is unfeasible.

Schlagwörter

Stichwörter der Autor:innen

Klebsiella pneumoniae KPCantibiotic resistancebeta lactam/beta lactamase inhibitorbiofilmcatheter-related bloodstream infectionssynergy test

Autor:innen und Institutionen

  • Department of Medicine and Surgery, Section of Infectious Diseases, University of Perugia, 06129 Perugia, Italy.
  • Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, 06129 Perugia, Italy.
  • Department of Medicine and Surgery and Center of Functional Genomics (C.U.R.Ge.F), University of Perugia, 06129 Perugia, Italy.
  • Department of Medicine and Surgery, Medical Microbiology Section, University of Perugia, 06129 Perugia, Italy.
  • Infectious Diseases Clinic, Santa Maria Hospital, 05100 Terni, Italy.
  • Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.

ORCID-Profile: Luigi Tordelli Ruda, Alicia Yoke Wei Wong, Andrea Tommasi, Giuseppe Vittorio De Socio, Roberta Spaccapelo, Donatella Pietrella, Antonella Mencacci, Claudia Monari, Samuele Sabbatini

Zitieren

APA

Papalini, C., Bicchieraro, G., Tordelli Ruda, L., Wong, A. Y. W., Battistelli, C., Genga, G., Tommasi, A., Gidari, A., Francisci, D., Socio, G. V., Spaccapelo, R., Pietrella, D., Mencacci, A., Monari, C., & Sabbatini, S. (2026). Targeting KPC-Producing Klebsiella pneumoniae Biofilms: Genomic Profiles, Clinical Outcomes and Novel Combinations. Microorganisms, 14(8), 1790. https://doi.org/10.3390/microorganisms14081790

Vancouver

Papalini C, Bicchieraro G, Tordelli Ruda L, Wong AYW, Battistelli C, Genga G, et al. Targeting KPC-Producing Klebsiella pneumoniae Biofilms: Genomic Profiles, Clinical Outcomes and Novel Combinations. Microorganisms. 2026;14(8):1790. doi:10.3390/microorganisms14081790

BibTeX
@article{Papalini2026,
  author = {Papalini, Chiara and Bicchieraro, Giulia and Tordelli Ruda, Luigi and Wong, Alicia Yoke Wei and Battistelli, Claudia and Genga, Giovanni and Tommasi, Andrea and Gidari, Anna and Francisci, Daniela and Socio, Giuseppe Vittorio De and Spaccapelo, Roberta and Pietrella, Donatella and Mencacci, Antonella and Monari, Claudia and Sabbatini, Samuele},
  title = {Targeting KPC-Producing Klebsiella pneumoniae Biofilms: Genomic Profiles, Clinical Outcomes and Novel Combinations},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {1790},
  doi = {10.3390/microorganisms14081790}
}
Kostenlos starten →